Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in <it>Vitro</it> and in <it>Vivo</it>
<p>Abstract</p> <p>Background</p> <p>Cyclooxygenase-2(COX-2) promotes carcinogenesis, tumor proliferation, angiogenesis, prevention of apoptosis, and immunosuppression. Meanwhile, COX-2 over-expression has been associated with tumor behavior and prognosis in several can...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://www.cancerci.com/content/12/1/53 |